A Prospective Real-world Study of Cadonilimab in Patients With Recurrent or Metastatic Cervical Cancer
NCT06155422
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
670
Enrollment
OTHER
Sponsor class
Conditions
Recurrent or Metastatic Cervical Cancer
Interventions
DRUG:
Cadonilimab
Sponsor
Gang Chen (101199)